Tatva Chintan Pharma IPO is second-most subscribed this year at 180 times

Is second only to MTAR Tech; Tatva's 3.26-million share offering garnered bids for 588 million shares, generating demand worth Rs 63,713 crore

Tatva Chintan Pharma Chem’s IPO has garnered 180 times subscription, making it the second-most subscribed offering of the year. The 3.26-million share offering garnered bids for 588 million shares, generating demand worth Rs 63,713 crore. The institutional investor portion of the IPO was subscribed 185 times, the high networth individual (HNI) portion was subscribed 512 time and the retail portion garnered 35 times subscription. In March, the IPO of MTAR Technologies had garnered 200 times subscription.

Tatva Chintan is a chemical manufacturing company that produces structure-directing agents (SDAs), phase transfer catalyst (PTCs), electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical